Biopharmaceutical News and Research

RSS
Combination targets offer new hope in fight against cancer

Combination targets offer new hope in fight against cancer

Orexigen presents findings on obesity drug candidates

Orexigen presents findings on obesity drug candidates

New analyses of long-term LIALDA (mesalamine) data presented at ACG

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Biopharmaceutical infrastructure key to lower drug development costs

Biopharmaceutical infrastructure key to lower drug development costs

Aida granted new anti-cancer patent

Aida granted new anti-cancer patent

Wyeth Pharmaceuticals to acquire Haptogen

Wyeth Pharmaceuticals to acquire Haptogen

Blood protein detects lung cancer, even at earliest stage

Blood protein detects lung cancer, even at earliest stage

New green methods for coating drugs in plastics

New green methods for coating drugs in plastics

New drugs to combat bioterrorism

New drugs to combat bioterrorism

New strategy for treating allergic disorders

New strategy for treating allergic disorders

Schering-Plough announces licensing of Acadesine

Schering-Plough announces licensing of Acadesine

Cancer survivors share their advice in new book

Cancer survivors share their advice in new book

Roche and Alnylam form RNAi therapeutics alliance

Roche and Alnylam form RNAi therapeutics alliance

Experimental Alzheimer's drug begins clinical trials

Experimental Alzheimer's drug begins clinical trials

Arpida receives FDA approval to initiate Phase II trial with intravenous iclaprim

Arpida receives FDA approval to initiate Phase II trial with intravenous iclaprim

Iloperidone shows promise for Akathisia

Iloperidone shows promise for Akathisia

Ulcerative colitis disruptive in relationships

Ulcerative colitis disruptive in relationships

Smokeless cannabis-vaporizing device may help those with HIV-related neuropathy

Smokeless cannabis-vaporizing device may help those with HIV-related neuropathy

New treatment for warts

New treatment for warts

Sigma-Aldrich acquires Molecular Medicine BioServices

Sigma-Aldrich acquires Molecular Medicine BioServices